Blonanserin

DRUG2 trials

Sponsors

Sumitomo Pharma (Suzhou) Co., Ltd.

Conditions

BlonanserinCognition FunctionFirst Episode SchizophreniaSchizophreniaSocial Function

Phase 3

Efficiency Study to Investigate Blonanserin in Treatment of Schizophrenia When Compared With Risperidone

CompletedNCT01516424

Sumitomo Pharma (Suzhou) Co., Ltd.Schizophrenia

Start: 2012-02-29End: 2013-02-28Updated: 2018-11-27

Phase 4

Effects on Social and Cognition Functions of Blonanserin in First Episode Schizophrenia Patients

TerminatedNCT03784222

Sumitomo Pharma (Suzhou) Co., Ltd.Blonanserin, Cognition Function, First Episode Schizophrenia +1

Start: 2019-01-22End: 2022-11-22Updated: 2024-04-19

Related Papers

Effectiveness and safety of blonanserin for improving social and cognitive functions in patients with first-episode schizophrenia: a study protocol for a prospective, multicentre, single-arm clinical trial

BMJ Open2022-04-013 citations